Kitov Pharmaceuticals (KTOV) announced the pricing of its follow-on offering. The company has priced public offering of 2,378,823 Class A units at $3.40 per unit and 1,150,589 Class B units also at $3.40. Each Class A unit consists of one American Depositary Share (ADS) and a listed warrant (symbol: KTOVW") to purchase one ADS at $3.78. Each ADS equals 20 ordinary shares of Kitov. The listed warrants will expire on November 25, 2020. Each Class B unit consists of one non-listed pre-funded warrant to purchase one ADS and one listed warrant to purchase one ADS. The non-listed warrants will be exercisable for 10 years from the date of issuance at an exercise price of $0.01 per ADS.